- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.99 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 2 x NA: SODIUM ION(Non-functional Binders)
- 3 x TGL: TRISTEAROYLGLYCEROL(Non-covalent)
TGL.6: 18 residues within 4Å:- Chain A: F.346, T.354, Y.379, N.422, F.426, H.429, F.430, L.433
- Chain B: L.7, G.8, H.24, L.28, V.31, F.32, S.35, L.39
- Chain I: Y.35, R.43
14 PLIP interactions:5 interactions with chain B, 7 interactions with chain A, 2 interactions with chain I- Hydrophobic interactions: B:L.7, B:V.31, B:F.32, A:F.346, A:T.354, A:N.422, A:F.426, A:H.429, A:F.430, A:F.430
- Water bridges: B:F.9, I:R.43
- Salt bridges: B:H.24, I:R.43
TGL.33: 24 residues within 4Å:- Chain A: W.334, M.339, L.342, G.343, K.411, F.414, A.415, F.418, V.419
- Chain B: I.42, L.46, T.47, T.48, K.49
- Chain D: R.73, S.74, T.75, E.77, W.78, V.81, M.86, I.89
- Chain I: R.16, H.20
14 PLIP interactions:8 interactions with chain A, 5 interactions with chain D, 1 interactions with chain B- Hydrophobic interactions: A:W.334, A:W.334, A:K.411, A:F.414, A:F.414, A:F.418, A:V.419, D:E.77, D:V.81, D:I.89, B:K.49
- Salt bridges: A:K.411
- Hydrogen bonds: D:T.75, D:W.78
TGL.45: 23 residues within 4Å:- Chain A: T.17, L.18, L.21, F.22, W.25, W.81, P.106, L.113, F.393, F.400, S.401, I.472
- Chain L: N.10, I.11, P.12, F.13, S.14, R.20, M.24, M.25, F.28, F.29, S.31
22 PLIP interactions:10 interactions with chain L, 12 interactions with chain A- Hydrophobic interactions: L:I.11, L:P.12, L:F.13, L:F.13, L:F.13, L:F.13, L:F.28, L:F.28, L:F.29, L:F.29, A:T.17, A:L.18, A:L.21, A:F.22, A:W.25, A:W.25, A:W.25, A:W.81, A:L.113, A:F.393, A:F.400, A:I.472
- 4 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
PGV.7: 27 residues within 4Å:- Chain A: F.94, P.95, R.96, M.97, F.148, V.155, I.158, P.200
- Chain C: H.8, V.10, G.19, A.23, M.26, T.27, L.30, N.49, T.52, M.53, W.56, W.57, V.60, E.63, H.70, L.78, G.81
- Ligands: PEK.22, PGV.24
15 PLIP interactions:8 interactions with chain C, 7 interactions with chain A- Hydrophobic interactions: C:A.23, C:L.30, C:T.52, C:W.56, C:W.56, C:W.56, C:W.57, A:F.148, A:V.155, A:I.158, A:P.200
- Water bridges: C:M.82
- Hydrogen bonds: A:R.96, A:M.97
- Salt bridges: A:R.96
PGV.24: 26 residues within 4Å:- Chain C: M.50, M.53, W.57, V.60, I.61, S.64, T.65, H.70, M.82, F.85, E.89, L.205, H.206, I.209, T.212, F.213, R.220, H.225, F.226, T.227, H.230, H.231, F.232, G.233
- Ligands: PGV.7, CDL.26
30 PLIP interactions:28 interactions with chain C, 2 interactions with chain F- Hydrophobic interactions: C:W.57, C:W.57, C:W.57, C:W.57, C:W.57, C:W.57, C:I.61, C:F.85, C:F.85, C:L.205, C:I.209, C:I.209, C:T.212, C:F.213, C:F.213, C:F.213, C:F.213
- Hydrogen bonds: C:S.64, C:R.220, C:F.232, C:G.233
- Water bridges: C:S.64, C:R.220, C:H.230, C:H.230, F:Q.12, F:E.17
- Salt bridges: C:R.220, C:R.220, C:H.230
PGV.25: 9 residues within 4Å:- Chain A: W.288
- Chain C: V.90, T.94, W.98, H.102, L.105, A.106
- Chain H: N.24
- Ligands: CHD.20
7 PLIP interactions:6 interactions with chain C, 1 interactions with chain A- Hydrophobic interactions: C:V.90, C:T.94, C:W.98, C:W.98, C:W.98, A:W.288
- Salt bridges: C:H.102
PGV.46: 17 residues within 4Å:- Chain A: N.406, T.408, W.409, R.480
- Chain D: T.80, A.84, F.87
- Chain K: F.9, H.10
- Chain M: A.3, K.4, P.5, P.12, Q.15, A.16, L.19, S.20
18 PLIP interactions:3 interactions with chain K, 6 interactions with chain M, 5 interactions with chain A, 4 interactions with chain D- Hydrophobic interactions: K:F.9, K:F.9, M:P.12, M:Q.15, M:A.16, M:L.19, A:T.408, A:W.409, A:W.409, A:W.409, D:T.80, D:A.84, D:F.87, D:F.87
- Salt bridges: K:H.10
- Water bridges: M:A.3, M:A.3
- Hydrogen bonds: A:T.408
- 19 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.8: 6 residues within 4Å:- Chain A: E.507
- Chain C: T.4
- Chain F: P.30, N.32, P.50, R.56
Ligand excluded by PLIPEDO.9: 7 residues within 4Å:- Chain A: Y.260, Y.261, V.394, H.395, P.398, W.494
- Chain M: I.1
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: L.136, A.137
- Chain B: Q.103, W.104
Ligand excluded by PLIPEDO.11: 8 residues within 4Å:- Chain A: M.390, F.393, V.394, L.405, A.410, H.413, M.468, I.471
Ligand excluded by PLIPEDO.12: 7 residues within 4Å:- Chain A: P.182, H.256, T.259, K.265, T.490, N.491
- Ligands: EDO.40
Ligand excluded by PLIPEDO.13: 4 residues within 4Å:- Chain A: K.265, T.489
- Chain F: I.70, S.84
Ligand excluded by PLIPEDO.14: 7 residues within 4Å:- Chain A: L.483, V.485, T.488, W.494, G.497, C.498
- Chain D: Y.11
Ligand excluded by PLIPEDO.15: 7 residues within 4Å:- Chain A: Y.19, N.80, N.98, S.101, G.160, N.163, F.164
Ligand excluded by PLIPEDO.16: 7 residues within 4Å:- Chain A: M.71, P.72, I.75, G.76, L.105, S.157, L.195
Ligand excluded by PLIPEDO.19: 2 residues within 4Å:- Chain B: E.157
- Ligands: EDO.30
Ligand excluded by PLIPEDO.28: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPEDO.29: 2 residues within 4Å:- Chain C: M.39
- Ligands: DMU.31
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain A: P.222
- Chain B: G.177
- Chain C: E.110
- Chain H: W.68
- Ligands: EDO.19
Ligand excluded by PLIPEDO.34: 6 residues within 4Å:- Chain D: P.14, D.26
- Chain E: W.27, R.30
- Ligands: EDO.35, EDO.41
Ligand excluded by PLIPEDO.35: 8 residues within 4Å:- Chain D: Y.22, D.26
- Chain E: W.27, R.30, K.31, N.34
- Chain F: P.83
- Ligands: EDO.34
Ligand excluded by PLIPEDO.37: 4 residues within 4Å:- Chain E: Y.18, K.21, I.24, E.28
Ligand excluded by PLIPEDO.39: 3 residues within 4Å:- Chain C: H.230
- Chain F: D.9, E.17
Ligand excluded by PLIPEDO.40: 7 residues within 4Å:- Chain A: T.489, T.490
- Chain F: S.67, T.68, V.69, W.71
- Ligands: EDO.12
Ligand excluded by PLIPEDO.41: 5 residues within 4Å:- Chain F: F.72, Q.80, R.81, P.83
- Ligands: EDO.34
Ligand excluded by PLIP- 1 x CUA: DINUCLEAR COPPER ION(Non-covalent)
- 4 x CHD: CHOLIC ACID(Non-covalent)
CHD.18: 7 residues within 4Å:- Chain A: M.271, G.272, W.275
- Chain B: Q.59, E.62, T.63, T.66
6 PLIP interactions:2 interactions with chain B, 4 interactions with chain A- Hydrogen bonds: B:Q.59, B:E.62
- Hydrophobic interactions: A:M.271, A:W.275, A:W.275, A:W.275
CHD.20: 9 residues within 4Å:- Chain A: H.233, W.288, M.297, D.300, T.301, Y.304
- Chain C: W.98, H.102
- Ligands: PGV.25
6 PLIP interactions:2 interactions with chain C, 4 interactions with chain A- Hydrophobic interactions: C:W.98, A:W.288, A:Y.304
- Salt bridges: C:H.102, A:H.233
- Hydrogen bonds: A:T.301
CHD.27: 5 residues within 4Å:- Chain C: R.155, L.159, F.163, L.222
- Chain J: F.1
7 PLIP interactions:6 interactions with chain C, 1 interactions with chain J- Hydrophobic interactions: C:L.159, C:F.163, C:F.163, C:F.163, C:L.222
- Salt bridges: C:R.155
- Hydrogen bonds: J:F.1
CHD.44: 7 residues within 4Å:- Chain A: I.3, L.7
- Chain J: Y.32, R.33, M.36, T.37, L.40
6 PLIP interactions:5 interactions with chain J, 1 interactions with chain A- Hydrophobic interactions: J:Y.32, J:M.36, J:L.40, A:I.3
- Hydrogen bonds: J:R.33, J:R.33
- 3 x PEK: (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE(Non-covalent)
PEK.22: 26 residues within 4Å:- Chain A: H.151, V.155, A.203, T.207, L.210, L.215
- Chain C: W.33, F.34, Y.180, Y.181, A.183, F.185, T.186, I.187, F.197, G.201, F.202, G.204, L.205
- Chain G: W.62, T.68, F.69, F.70, H.71, N.76
- Ligands: PGV.7
15 PLIP interactions:3 interactions with chain A, 7 interactions with chain G, 5 interactions with chain C- Hydrophobic interactions: A:V.155, A:A.203, A:L.210, G:F.69, C:W.33, C:F.34, C:I.187, C:F.202
- Hydrogen bonds: G:T.68, G:F.70, G:N.76, G:N.76, C:I.187
- Water bridges: G:F.69, G:F.69
PEK.23: 11 residues within 4Å:- Chain C: K.156, H.157, Q.160
- Chain F: A.1
- Chain G: R.17, F.21, G.22, L.23, L.25, V.28
- Ligands: CDL.42
9 PLIP interactions:6 interactions with chain G, 1 interactions with chain F, 2 interactions with chain C- Hydrophobic interactions: G:F.21, G:L.23, G:L.25, G:V.28
- Hydrogen bonds: G:R.17, F:A.1, C:K.156, C:K.156
- Salt bridges: G:R.17
PEK.43: 6 residues within 4Å:- Chain G: S.2, K.5, D.7, H.8, T.11
- Ligands: CDL.42
1 PLIP interactions:1 interactions with chain G- Hydrophobic interactions: G:K.5
- 2 x CDL: CARDIOLIPIN(Non-covalent)
CDL.26: 23 residues within 4Å:- Chain C: M.50, L.51, M.53, Y.54, W.57, R.58, I.61, R.62, F.66, T.173, S.211, T.212, I.215, V.216, F.219, R.220, K.223, H.225
- Chain J: K.8, F.12, I.30, L.31
- Ligands: PGV.24
24 PLIP interactions:20 interactions with chain C, 4 interactions with chain J- Hydrophobic interactions: C:Y.54, C:Y.54, C:W.57, C:W.57, C:R.58, C:I.61, C:T.173, C:T.212, C:I.215, C:V.216, C:F.219, C:F.219, J:I.30, J:L.31
- Hydrogen bonds: C:Y.54, C:R.58
- Water bridges: C:R.58, C:R.62, J:D.28
- Salt bridges: C:R.62, C:K.223, C:K.223, C:H.225, J:K.8
CDL.42: 15 residues within 4Å:- Chain C: N.124, L.126, L.130, T.133, V.141, L.249, V.253
- Chain G: L.23, S.27, C.31, N.34, L.37, H.38
- Ligands: PEK.23, PEK.43
10 PLIP interactions:7 interactions with chain C, 3 interactions with chain G- Hydrophobic interactions: C:L.130, C:L.130, C:V.141, C:L.249, C:L.249, C:V.253
- Hydrogen bonds: C:N.124, G:N.34
- Salt bridges: G:H.38, G:H.38
- 3 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-covalent)
DMU.31: 10 residues within 4Å:- Chain C: M.32, N.37, S.38, T.40, I.44
- Chain J: G.41, G.42, Y.45
- Ligands: EDO.29, DMU.32
9 PLIP interactions:4 interactions with chain J, 5 interactions with chain C- Hydrophobic interactions: J:Y.45, J:Y.45, J:Y.45, C:I.44
- Hydrogen bonds: J:Y.45, C:N.37, C:N.37, C:S.38, C:T.40
DMU.32: 12 residues within 4Å:- Chain A: L.110, L.145
- Chain C: S.28, F.36
- Chain J: Y.45, S.46, Y.48, C.49, L.50, W.52, A.53
- Ligands: DMU.31
10 PLIP interactions:5 interactions with chain J, 2 interactions with chain A, 3 interactions with chain C- Hydrophobic interactions: J:L.50, J:W.52, J:A.53, A:L.110, A:L.145, C:F.36, C:F.36
- Hydrogen bonds: J:Y.45, J:Y.45, C:F.36
DMU.47: 12 residues within 4Å:- Chain A: L.35, F.459
- Chain D: L.95, W.98, Y.102
- Chain L: F.37
- Chain M: L.27, L.28, G.31, W.32, Y.35, H.36
10 PLIP interactions:4 interactions with chain D, 3 interactions with chain A, 2 interactions with chain M, 1 interactions with chain L- Hydrophobic interactions: D:L.95, D:W.98, D:W.98, D:W.98, A:L.35, A:F.459, A:F.459, M:L.27, M:L.27, L:F.37
- 1 x PSC: (7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE(Non-covalent)
PSC.36: 20 residues within 4Å:- Chain A: F.268, F.321, H.328
- Chain B: L.37, I.41, M.45, H.52, T.55, M.56, D.57, V.61, I.64, W.65
- Chain E: E.6, T.7, D.8, F.11
- Chain I: R.10, A.14, L.17
11 PLIP interactions:6 interactions with chain B, 3 interactions with chain A, 1 interactions with chain E, 1 interactions with chain I- Hydrophobic interactions: B:I.41, B:I.41, B:M.56, B:I.64, B:W.65, A:F.268, A:F.321, A:F.321, I:A.14
- Hydrogen bonds: B:D.57
- Salt bridges: E:D.8
- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Luo, F. et al., Structure of bovine cytochrome c oxidase in the ligand-free reduced state at neutral pH. Acta Crystallogr F Struct Biol Commun (2018)
- Release Date
- 2018-02-07
- Peptides
- Cytochrome c oxidase subunit 1: A
Cytochrome c oxidase subunit 2: B
Cytochrome c oxidase subunit 3: C
Cytochrome c oxidase subunit 4 isoform 1, mitochondrial: D
Cytochrome c oxidase subunit 5A, mitochondrial: E
Cytochrome c oxidase subunit 5B, mitochondrial: F
Cytochrome c oxidase subunit 6A2, mitochondrial: G
Cytochrome c oxidase subunit 6B1: H
Cytochrome c oxidase polypeptide VIc: I
Cytochrome c oxidase subunit VIIa-heart: J
Cytochrome c oxidase subunit VIIb: K
Cytochrome c oxidase subunit VIIc: L
Cytochrome c oxidase subunit VIII-heart: M - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
M - Membrane
-
We predict this structure to be a membrane protein.
SMTL ID : 5xdx.1 (1 other biounit)
Bovine heart cytochrome c oxidase in the reduced state with pH 7.3 at 1.99 angstrom resolution
Cytochrome c oxidase subunit 1
Cytochrome c oxidase subunit 2
Cytochrome c oxidase subunit 3
Cytochrome c oxidase subunit 4 isoform 1, mitochondrial
Cytochrome c oxidase subunit 5A, mitochondrial
Cytochrome c oxidase subunit 5B, mitochondrial
Cytochrome c oxidase subunit 6A2, mitochondrial
Cytochrome c oxidase subunit 6B1
Cytochrome c oxidase polypeptide VIc
Cytochrome c oxidase subunit VIIa-heart
Cytochrome c oxidase subunit VIIb
Cytochrome c oxidase subunit VIIc
Cytochrome c oxidase subunit VIII-heart
Related Entries With Identical Sequence
1occ.1 | 1oco.1 | 1ocr.1 | 1ocz.1 | 1v54.1 | 1v55.1 | 2dyr.1 | 2dys.1 | 2eij.1 | 2eik.1 | 2eil.1 | 2eim.1 | 2ein.1 | 2occ.1 | 2occ.2 | 2occ.3 | 2y69.1 | 2y69.2 | 2ybb.1 | 2zxw.1 | 2zxw.2 | 3abk.1 | 3abk.2 | 3abl.1 | 3abl.2 | 3abm.1 | 3abm.2 | 3ag1.1 | 3ag1.2 | 3ag2.1 more...less...3ag2.2 | 3ag3.1 | 3ag3.2 | 3ag4.1 | 3ag4.2 | 3asn.1 | 3asn.2 | 3aso.1 | 3aso.2 | 3wg7.1 | 3wg7.2 | 3x2q.1 | 3x2q.2 | 5b1a.1 | 5b1a.2 | 5b1b.1 | 5b1b.2 | 5b3s.1 | 5b3s.2 | 5gpn.49 | 5gpn.50 | 5gpn.53 | 5gpn.54 | 5gpn.55 | 5gpn.56 | 5gpn.57 | 5gpn.58 | 5gpn.59 | 5gpn.60 | 5gup.1 | 5gup.68 | 5gup.69 | 5gup.70 | 5gup.71 | 5gup.72 | 5gup.73 | 5gup.75 | 5gup.76 | 5gup.79 | 5iy5.1 | 5iy5.2 | 5luf.1 | 5w97.1 | 5wau.1 | 5x19.1 | 5x19.2 | 5x1b.1 | 5x1b.2 | 5x1f.1 | 5x1f.2 | 5xdq.1 | 5xdq.2 | 5xdx.2 | 5xth.46 | 5xth.47 | 5xth.50 | 5xth.54 | 5xth.57 | 5xti.46 | 5xti.47 | 5xti.50 | 5xti.54 | 5xti.57 | 5xti.126 | 5xti.127 | 5xti.130 | 5xti.134 | 5xti.137 | 5z84.1 | 5z84.2 | 5z85.1 | 5z85.2 | 5z86.1 | 5z86.2 | 5zco.1 | 5zco.2 | 5zcp.1 | 5zcp.2 | 5zcq.1 | 5zcq.2 | 6j8m.1 | 6j8m.2 | 6juw.1 | 6jy3.1 | 6jy4.1 | 6nkn.1 | 6nmf.1 | 6nmp.1 | 7coh.1 | 7coh.2 | 7cp5.1 | 7d5w.1 | 7d5x.1 | 7dgr.67 | 7dgr.68 | 7dgs.67 | 7dgs.68 | 7dkf.68 | 7dkf.69 | 7ev7.1 | 7ev7.2 | 7o37.1 | 7o3c.1 | 7o3e.1 | 7thu.1 | 7tie.1 | 7tih.1 | 7tii.1 | 7vuw.1 | 7vuw.2 | 7vvr.1 | 7vvr.2 | 7w3e.1 | 7w3e.2 | 7xma.1 | 7xma.2 | 7xmb.1 | 7xmb.2 | 7y44.1 | 7y44.2 | 7ypy.1 | 7ypy.2 | 8d4t.1 | 8gbt.1 | 8gcq.1 | 8gvm.1 | 8gvm.2 | 8h8r.1 | 8h8s.1 | 8ijn.1 | 8ijn.2